PatientsVille.com LogoPatientsVille.com

Post-Traumatic Stress Disorder | Post-Traumatic Stress Disorder (PTSD) and Seroquel

Post-Traumatic Stress Disorder research study

What is the primary objective of this study?

This 8 weeks study will investigate therapeutic responses to Seroquel pharmacotherapy in PTSD.

Who is eligible to participate?

Inclusion Criteria: - Provision of written informed consent - Fluency in English - A diagnosis of PTSD - No pregnancy - Right-handedness Exclusion Criteria: - Pregnancy or lactation - Any cognitive impairment that precludes informed consent - Known intolerance or lack of response to Seroquel - Previous enrollment or randomization of treatment in the present study - Participation in another drug trial within 4 weeks prior enrollment into this study - Patients with Diabetes Mellitus - History of allergic reaction or hypersensitivity to Seroquel - Contraindications to magnetic resonance imaging - Treatment with an effective medication for PTSD

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Post-Traumatic Stress Disorder

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Drug:SeroquelThis study will investigate therapeutic responses to Seroquel pharmacotherapy in PTSD

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

SeroquelThis study will investigate therapeutic responses to Seroquel pharmacotherapy in PTSD

Study Status

Completed

Start Date: February 2010

Completed Date: March 2015

Phase: N/A

Type: Interventional

Design:

Primary Outcome: Change From Baseline in PTSD Symptomatology at the Week 8 Timepoint.

Secondary Outcome:

Study sponsors, principal investigator, and references

Principal Investigator: Igor Elman, MD

Lead Sponsor: Cambridge Health Alliance

Collaborator:

More information:https://clinicaltrials.gov/show/NCT01066156

Discuss Seroquel